Thermo Fisher Scientific Inc. (NYSE:TMO) is considered one of the best low volatility stocks to buy by analysts. TD Cowen maintains a Buy rating on TMO but lowered its price target to $550 on July 16. The firm expects modest second quarter growth to boost TMO shares.

TD Cowen notes that biopharma activity in the second quarter was unaffected by tariff or MFN issues. The firm predicts “similar” organic growth to the first quarter, lowering its estimate from 1.2% to 1.0%, below the analysts’ consensus of 0.7%.

Thermo Fisher Scientific Inc. (NYSE:TMO) is a leading biotech and life sciences company in the U.S., offering a wide range of products and services. The company has experienced significant growth through strategic acquisitions, such as Affymetrix and Life Technologies.

While TMO shows potential as an investment, other AI stocks may offer greater upside with less downside risk. Investors seeking undervalued AI stock opportunities can explore the free report on the best short-term AI stock for potential gains.

Read more at Yahoo Finance: TD Cowen Sees Upside for Thermo Fisher (TMO) With Modest Q2 Growth